Contineum Therapeutics (CTNM) EPS (2024 - 2026)
Contineum Therapeutics (CTNM) EPS from Jun 30, 2024 to Mar 31, 2026. The TTM Contineum Therapeutics (CTNM) EPS is -$2.08. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Contineum Therapeutics (CTNM) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +4.17% |
Annual EPS change of Contineum Therapeutics (CTNM)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.39 | -82.11% |
| 2025 | -$2.17 | -0.84% |
| 2024 | -$2.18 | N/A |